cyclohexyl 2-pyridyl carbonate | 325952-80-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: cyclohexyl 2-pyridyl carbonate
• 英文别名: Carbonic acid cyclohexyl 2-pyridyl ester；cyclohexyl pyridin-2-yl carbonate
• CAS: 325952-80-5
• 化学式: C₁₂H₁₅NO₃
• 分子量: 221.256
• InChiKey: APLLAFLBDRXAHV-UHFFFAOYSA-N

物化性质

• 沸点：
  343.8±24.0 °C(Predicted)
• 密度：
  1.16±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  48.4
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  三氟乙酸 、 cyclohexyl 2-pyridyl carbonate 、 N-[2-[di(propan-2-yl)amino]ethyl]-6-phenylmethoxy-1,2,3,4-tetrahydroisoquinoline-1-carboxamide 在 三乙胺 作用下， 以 二氯甲烷 、 甲醇 、 水 为溶剂， 反应 12.0h， 以65%的产率得到cyclohexyl 6-(benzyloxy)-1-((2-(diisopropylamino)ethyl)carbamoyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate 2,2,2-trifluoroacetate
  参考文献：
  名称：

  Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity

  摘要：

  提供了四氢异喹啉类似物，它们是趋化因子受体活性的调节剂。其四氢异喹啉类似物具有以下结构，其中R1、R2、R3、R3a、X1、X2、X3、X4、m、n和p如本文所述。

  公开号：

  US06649606B1
• 作为产物：
  描述：

  碳酸二(2-吡啶)酯 、 环己醇 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 以98%的产率得到cyclohexyl 2-pyridyl carbonate
  参考文献：
  名称：

  Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity

  摘要：

  提供了四氢异喹啉类似物，它们是趋化因子受体活性的调节剂。其四氢异喹啉类似物具有以下结构，其中R1、R2、R3、R3a、X1、X2、X3、X4、m、n和p如本文所述。

  公开号：

  US06649606B1

文献信息

• [EN] DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA)<br/>[FR] BÊTA-LACTONES DISUBSTITUÉS EN TANT QU'INHIBITEURS DE L'AMIDASE ACIDE DE N-ACYLÉTHANOLAMINE (NAAA)
  申请人：UNIV CALIFORNIA

  公开号：WO2013078430A1

  公开（公告）日：2013-05-30

  The present invention provides compounds and pharmaceutical compositions for inhibiting N-acylethanolamine acid amidase (NAAA). Inhibition of NAAA is contemplated as a method to sustain the levels of palmitoylethanolamide (PEA) and oleylethanolamide (OEA), two substrates of NAAA, in conditions characterized by reduced concentrations of PEA and OEA. The invention also provides methods for treating inflammatory diseases and pain, and other disorders in which decreased levels of PEA and OEA are associated with the disorder.

  本发明提供了用于抑制N-酰乙醇胺酸酰胺酶（NAAA）的化合物和药物组合物。考虑到抑制NAAA是一种维持棕榈酰乙醇胺（PEA）和油酰乙醇胺（OEA）水平的方法，这两种物质是NAAA的底物，在特征为PEA和OEA浓度降低的情况下。该发明还提供了治疗炎症性疾病和疼痛以及其他与降低PEA和OEA水平相关的疾病的方法。
• A Convenient Method for the Preparations of Carboxamides and Peptides by Using Di(2-pyridyl) Carbonate and<b><i>O</i></b>,<b><i>O</i></b>^′-Di(2-pyridyl) Thiocarbonate as Dehydrating Reagents
  作者：Isamu Shiina、Yoshihito Suenaga、Masakazu Nakano、Teruaki Mukaiyama

  DOI：10.1246/bcsj.73.2811

  日期：2000.12

  di(2-pyridyl) carbonate (DPC) or O,O′-di(2-pyridyl) thiocarbonate (DPTC) in the presence of a catalytic amount of 4-(dimethylamino)pyridine (DMAP). The formation of 2-pyridyl esters, key intermediates of the reaction, from carboxylic acids by using DPC proceeded faster than by using DPTC; therefore, the former carbonate is more efficiently employed in the above condensation reactions.

  通过使用二（2-吡啶基）碳酸酯（DPC）或O，O'-二（2-吡啶基）硫代碳酸酯（DPTC）在存在下进行脱水缩合，从游离羧酸和胺中以高产率制备羧酰胺和肽催化量的 4-（二甲氨基）吡啶 (DMAP)。与使用 DPTC 相比，使用 DPC 由羧酸形成 2-吡啶基酯（反应的关键中间体）的速度更快；因此，在上述缩合反应中更有效地使用前一种碳酸酯。
• Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA)
  申请人：The Regents of the University of California

  公开号：US09353075B2

  公开（公告）日：2016-05-31

  The present invention provides compounds and pharmaceutical compositions for inhibiting N-acylethanolamine acid amidase (NAAA). Inhibition of NAAA is contemplated as a method to sustain the levels of palmitoylethanolamide (PEA) and oleylethanolamide (OEA), two substrates of NAAA, in conditions characterized by reduced concentrations of PEA and OEA. The invention also provides methods for treating inflammatory diseases and pain, and other disorders in which decreased levels of PEA and OEA are associated with the disorder.

  本发明提供了用于抑制N-酰基乙醇胺酸酰胺酶（NAAA）的化合物和药物组合物。考虑到抑制NAAA是一种维持棕榈酰乙醇胺（PEA）和油酰乙醇胺（OEA）水平的方法，在特征为PEA和OEA浓度降低的情况下。该发明还提供了治疗炎症性疾病和疼痛以及其他与降低PEA和OEA水平相关的紊乱的方法。
• Disubstituted Beta-lactones as Inhibitors of N-Acylethanolamine Acid Amidase (NAAA)
  申请人：The Regents of the University of California

  公开号：US20130281490A1

  公开（公告）日：2013-10-24

  The present invention provides compounds and pharmaceutical compositions for inhibiting N-acylethanolamine acid amidase (NAAA). Inhibition of NAAA is contemplated as a method to sustain the levels of palmitoylethanolamide (PEA) and oleylethanolamide (OEA), two substrates of NAAA, in conditions characterized by reduced concentrations of PEA and OEA. The invention also provides methods for treating inflammatory diseases and pain, and other disorders in which decreased levels of PEA and OEA are associated with the disorder.

  本发明提供了一种抑制N-酰乙醇胺酸酰胺酶（NAAA）的化合物和制药组合物。抑制NAAA被认为是一种维持在低浓度下的PEA和OEA的水平的方法，这两种物质是NAAA的底物。本发明还提供了治疗炎症性疾病、疼痛和其他与PEA和OEA浓度降低相关的疾病的方法。
• DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA)
  申请人：Fondazione Istituto Italiano Di Tecnologia

  公开号：US20160235707A1

  公开（公告）日：2016-08-18

  The present invention provides compounds and pharmaceutical compositions for inhibiting N-acylethanolamine acid amidase (NAAA). Inhibition of NAAA is contemplated as a method to sustain the levels of palmitoylethanolamide (PEA) and oleylethanolamide (OEA), two substrates of NAAA, in conditions characterized by reduced concentrations of PEA and OEA. The invention also provides methods for treating inflammatory diseases and pain, and other disorders in which decreased levels of PEA and OEA are associated with the disorder.

  本发明提供了用于抑制N-乙酰基乙醇胺酸酰化酶（NAAA）的化合物和制药组合物。抑制NAAA被认为是一种维持在PEA和OEA两种NAAA底物的水平在浓度降低的情况下的方法。本发明还提供了用于治疗炎症性疾病和疼痛以及其他与PEA和OEA水平下降相关的疾病的方法。